University Of Toledo Medical Center is a medicare approved dialysis facility center in Toledo, Ohio and it has 6 dialysis stations. It is located in Lucas county at 3000 Arlington Ave., Rm 0239, Toledo, OH, 43614. You can reach out to the office of University Of Toledo Medical Center at (419) 383-4985. This dialysis clinic is run as an Independent entity i.e it is not owned by any chain organization. University Of Toledo Medical Center has the following ownership type - Profit. It was first certified by medicare in June, 2009. The medicare id for this facility is 360048 and it accepts patients under medicare ESRD program.
| Name | University Of Toledo Medical Center |
|---|---|
| Location | 3000 Arlington Ave., Rm 0239, Toledo, Ohio |
| No. of Dialysis Stations | 6 |
| Medicare ID | 360048 |
| Managed By | Independent |
| Ownership Type | Profit |
| Late Shifts | No |
| 3000 Arlington Ave., Rm 0239, Toledo, Ohio, 43614 | |
| (419) 383-4985 | |
| Not Available |
News Archive
U.N. Secretary-General Ban Ki-moon "has received preliminary pledges of support for a second five-year term … from the United States and other key members of the Security Council, U.N. diplomats said," Reuters reports in an article that examines Ban's first term at the U.N., set to end on Dec. 31. Although Ban has yet to officially announce his candidacy for re-election, diplomats say Ban has expressed interest in doing so.
CaridianBCT, a leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, today announced that a panel of medical and scientific experts have endorsed the effectiveness of the Mirasol® Pathogen Reduction Technology System for replacing gamma irradiation, the current standard of care for preventing transfusion-related Graft vs. Host Disease in platelet recipients.
As Switzerland enters Phase 3 of COVID-19 restrictions, Zurich-based VirtaMed brings medical training to hospitals across the country with a mobile surgical simulation lab.
The Cardiovascular Research Foundation announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago
| NPI Number | 1154384204 |
| Organization Name | University Of Toledo Medical Center |
| Doing Business As | Medical University Of Ohio At Toledo |
| Address | 3000 Arlington Ave Toledo, Ohio, 43614 |
| Phone Number | (419) 383-4000 |
News Archive
U.N. Secretary-General Ban Ki-moon "has received preliminary pledges of support for a second five-year term … from the United States and other key members of the Security Council, U.N. diplomats said," Reuters reports in an article that examines Ban's first term at the U.N., set to end on Dec. 31. Although Ban has yet to officially announce his candidacy for re-election, diplomats say Ban has expressed interest in doing so.
CaridianBCT, a leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, today announced that a panel of medical and scientific experts have endorsed the effectiveness of the Mirasol® Pathogen Reduction Technology System for replacing gamma irradiation, the current standard of care for preventing transfusion-related Graft vs. Host Disease in platelet recipients.
As Switzerland enters Phase 3 of COVID-19 restrictions, Zurich-based VirtaMed brings medical training to hospitals across the country with a mobile surgical simulation lab.
The Cardiovascular Research Foundation announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 7 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 36 |
| Percentage of adult patients getting regular hemodialysis at the center | |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
U.N. Secretary-General Ban Ki-moon "has received preliminary pledges of support for a second five-year term … from the United States and other key members of the Security Council, U.N. diplomats said," Reuters reports in an article that examines Ban's first term at the U.N., set to end on Dec. 31. Although Ban has yet to officially announce his candidacy for re-election, diplomats say Ban has expressed interest in doing so.
CaridianBCT, a leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, today announced that a panel of medical and scientific experts have endorsed the effectiveness of the Mirasol® Pathogen Reduction Technology System for replacing gamma irradiation, the current standard of care for preventing transfusion-related Graft vs. Host Disease in platelet recipients.
As Switzerland enters Phase 3 of COVID-19 restrictions, Zurich-based VirtaMed brings medical training to hospitals across the country with a mobile surgical simulation lab.
The Cardiovascular Research Foundation announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at University Of Toledo Medical Center with elevated calcium levels.
| Patients with hypercalcemia | 8 |
| Hypercalcemia patient months | 48 |
| Hypercalcemia patients with serumcalcium greater than 10.2 mg | |
| Patients with Serumphosphor | 7 |
| Patients with Serumphosphor less than 3.5 mg/dL | |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | |
| Patients with Serumphosphor greater than 7 mg/dL |
News Archive
U.N. Secretary-General Ban Ki-moon "has received preliminary pledges of support for a second five-year term … from the United States and other key members of the Security Council, U.N. diplomats said," Reuters reports in an article that examines Ban's first term at the U.N., set to end on Dec. 31. Although Ban has yet to officially announce his candidacy for re-election, diplomats say Ban has expressed interest in doing so.
CaridianBCT, a leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, today announced that a panel of medical and scientific experts have endorsed the effectiveness of the Mirasol® Pathogen Reduction Technology System for replacing gamma irradiation, the current standard of care for preventing transfusion-related Graft vs. Host Disease in platelet recipients.
As Switzerland enters Phase 3 of COVID-19 restrictions, Zurich-based VirtaMed brings medical training to hospitals across the country with a mobile surgical simulation lab.
The Cardiovascular Research Foundation announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 67 |
| Patient months included in arterial venous fistula and catheter summaries | 89 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 47 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 13 |
News Archive
U.N. Secretary-General Ban Ki-moon "has received preliminary pledges of support for a second five-year term … from the United States and other key members of the Security Council, U.N. diplomats said," Reuters reports in an article that examines Ban's first term at the U.N., set to end on Dec. 31. Although Ban has yet to officially announce his candidacy for re-election, diplomats say Ban has expressed interest in doing so.
CaridianBCT, a leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, today announced that a panel of medical and scientific experts have endorsed the effectiveness of the Mirasol® Pathogen Reduction Technology System for replacing gamma irradiation, the current standard of care for preventing transfusion-related Graft vs. Host Disease in platelet recipients.
As Switzerland enters Phase 3 of COVID-19 restrictions, Zurich-based VirtaMed brings medical training to hospitals across the country with a mobile surgical simulation lab.
The Cardiovascular Research Foundation announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 4 |
| Hospitalization Rate in facility | (Not Available) |
| Hospitalization Rate: Upper Confidence Limit | |
| Hospitalization Rate: Lower Confidence Limit |
News Archive
U.N. Secretary-General Ban Ki-moon "has received preliminary pledges of support for a second five-year term … from the United States and other key members of the Security Council, U.N. diplomats said," Reuters reports in an article that examines Ban's first term at the U.N., set to end on Dec. 31. Although Ban has yet to officially announce his candidacy for re-election, diplomats say Ban has expressed interest in doing so.
CaridianBCT, a leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, today announced that a panel of medical and scientific experts have endorsed the effectiveness of the Mirasol® Pathogen Reduction Technology System for replacing gamma irradiation, the current standard of care for preventing transfusion-related Graft vs. Host Disease in platelet recipients.
As Switzerland enters Phase 3 of COVID-19 restrictions, Zurich-based VirtaMed brings medical training to hospitals across the country with a mobile surgical simulation lab.
The Cardiovascular Research Foundation announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago
The rate of readmission show you whether patients who were being treated regularly at University Of Toledo Medical Center were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 44.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 66.1 |
| Readmission Rate: Lower Confidence Limit | 25.5 |
News Archive
U.N. Secretary-General Ban Ki-moon "has received preliminary pledges of support for a second five-year term … from the United States and other key members of the Security Council, U.N. diplomats said," Reuters reports in an article that examines Ban's first term at the U.N., set to end on Dec. 31. Although Ban has yet to officially announce his candidacy for re-election, diplomats say Ban has expressed interest in doing so.
CaridianBCT, a leading global provider of technology, products and services in the blood banking, transfusion medicine and cell therapy industries, today announced that a panel of medical and scientific experts have endorsed the effectiveness of the Mirasol® Pathogen Reduction Technology System for replacing gamma irradiation, the current standard of care for preventing transfusion-related Graft vs. Host Disease in platelet recipients.
As Switzerland enters Phase 3 of COVID-19 restrictions, Zurich-based VirtaMed brings medical training to hospitals across the country with a mobile surgical simulation lab.
The Cardiovascular Research Foundation announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.
"I'm inspired when I see the growing number and quality of health market innovations now emerging in the developing world," Gina Lagomarsino, a principal and managing director at Results for Development Institute (R4D), writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog.
› Verified 7 days ago